Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Australia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20111
20151
20162
20171
20183
20192
20204
20213
20223
20232
20249
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Active, not recruiting7
Terminated7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Pfizer3
MacroGenics2
Monopar Therapeutics2
Panbela Therapeutics, Inc.2
AbbVie1
Actym Therapeutics, Inc.1
Amgen1
Arbele Pty Ltd1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms37
Ovarian Neoplasms17
Carcinoma, Non-Small-Cell Lung16
Colorectal Neoplasms16
Neoplasm Metastasis12
Triple Negative Breast Neoplasms12
Breast Neoplasms11
Urinary Bladder Neoplasms10
Uterine Cervical Neoplasms10
Stomach Neoplasms9

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.